Evidence-Based Medicine

Turner Syndrome

Turner Syndrome

Background

  • Turner syndrome is a genetic syndrome characterized by short stature, absent or delayed puberty, infertility, cardiac malformations, renal abnormalities, learning difficulties, skeletal abnormalities, and osteoporosis.
  • Caused by a lack of 1 sex chromosome in a phenotypic female.

Evaluation

  • Diagnosis of Turner syndrome should be considered in a female with slow growth, short stature, delayed or absent puberty, learning difficulties, primary amenorrhea, infertility, or multiple miscarriages.
  • Clinical manifestations suggestive of Turner syndrome include
    • short stature
    • lymphedema, especially of the hands and feet
    • absent pubertal signs
    • webbed neck
    • low posterior hairline
    • broad, flat chest with wide-spaced nipples
    • premature ovarian failure or ovarian hypofunction
    • coarctation of the aorta or aortic valve abnormalities
  • Diagnosis is confirmed by karyotype demonstrating a partial or complete absence of 1 X chromosome.
  • Skin biopsy for mosaicism can be performed if the karyotype is normal but still clinically suspected.
  • Echocardiography and renal ultrasound should be performed upon diagnosis to assess for associated abnormalities.

Management

  • Growth hormone, estrogens, and androgens may be used individually or in combinations to improve final height and body proportions.
    • Growth hormones should be considered as soon as growth failure is identified, although there is no clear evidence for when to initiate treatment.
    • Estrogens should be considered in adolescents who have not demonstrated spontaneous development of secondary sex characteristics and have high follicle-stimulating hormone levels.
    • Androgens may be used as adjunctive therapy to growth hormones if diagnosis is made later (age 9 years or later) or in children with extreme short stature.
  • Calcium and vitamin D supplementation is recommended to prevent osteoporosis.
  • Additional health maintenance screening is indicated for prevention and monitoring of complications associated with Turner syndrome, such as hypertension, hypothyroidism, diabetes, and neurocognitive problems.

Published: 08-07-2023 Updeted: 08-07-2023

References

  1. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med. 2004 Sep 16;351(12):1227-38
  2. Gravholt C, Andersen N, Conway G, et al; International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017 Sep;177(3):G1-G70
  3. Morgan T. Turner syndrome: diagnosis and management. Am Fam Physician. 2007 Aug 1;76(3):405-10
  4. Pinsker JE. Clinical review: Turner syndrome: updating the paradigm of clinical care. J Clin Endocrinol Metab. 2012 Jun;97(6):E994-1003

Related Topics